These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 26481628)

  • 21. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
    Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB
    J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and mutation analysis of Tpit in the canine pituitary gland and corticotroph adenomas.
    Hanson JM; Mol JA; Leegwater PA; Bilodeau S; Drouin J; Meij BP
    Domest Anim Endocrinol; 2008 Apr; 34(3):217-22. PubMed ID: 17544240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas.
    Kim D; Ku CR; Park SH; Moon JH; Kim EH; Kim SH; Lee EJ
    World Neurosurg; 2018 Jul; 115():e464-e471. PubMed ID: 29678704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation of silent corticotroph pituitary neuroendocrine tumors (PitNETs) from non-functioning PitNETs using kinetic analysis of dynamic MRI.
    Amano T; Masumoto T; Watanabe D; Hoshiai S; Mori K; Sakamoto N; Kino H; Akutsu H; Nakajima T
    Jpn J Radiol; 2023 Sep; 41(9):938-946. PubMed ID: 37027094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comprehensive long-term retrospective analysis of silent corticotrophic adenomas vs hormone-negative adenomas.
    Jahangiri A; Wagner JR; Pekmezci M; Hiniker A; Chang EF; Kunwar S; Blevins L; Aghi MK
    Neurosurgery; 2013 Jul; 73(1):8-17; discussion 17-8. PubMed ID: 23685641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pituitary transcription factors: from congenital deficiencies to gene therapy.
    Quentien MH; Barlier A; Franc JL; Pellegrini I; Brue T; Enjalbert A
    J Neuroendocrinol; 2006 Sep; 18(9):633-42. PubMed ID: 16879162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular determinants of pituitary cytodifferentiation.
    Asa SL; Ezzat S
    Pituitary; 1999 May; 1(3-4):159-68. PubMed ID: 11081194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proposal of a clinically relevant working classification of pituitary neuroendocrine tumors based on pituitary transcription factors.
    Silva-Ortega S; García-Martinez A; Niveiro de Jaime M; Torregrosa ME; Abarca J; Monjas I; Picó Alfonso A; Aranda López I
    Hum Pathol; 2021 Apr; 110():20-30. PubMed ID: 33321163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PROP1 overexpression in corticotrophinomas: evidence for the role of PROP1 in the maintenance of cells committed to corticotrophic differentiation.
    Araujo RV; Chang CV; Cescato VA; Fragoso MC; Bronstein MD; Mendonca BB; Arnhold IJ; Carvalho LR
    Clinics (Sao Paulo); 2013 Jun; 68(6):887-91. PubMed ID: 23778486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double adenomas of the pituitary: transcription factors Pit-1, T-pit, and SF-1 identify cytogenesis and differentiation.
    Jastania RA; Alsaad KO; Al-Shraim M; Kovacs K; Asa SL
    Endocr Pathol; 2005; 16(3):187-94. PubMed ID: 16299401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of adrenocorticotropic hormone, prolactin and transcriptional factors in clinically nonfunctioning pituitary adenoma.
    Kageyama K; Ikeda H; Nigawara T; Sakihara S; Suda T
    Endocr J; 2007 Dec; 54(6):961-8. PubMed ID: 18079591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MSH6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes.
    Uraki S; Ariyasu H; Doi A; Takeshima K; Morita S; Inaba H; Furuta H; Fukuhara N; Inoshita N; Nishioka H; Nakao N; Yamada S; Akamizu T
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silent corticotroph adenomas: Emory University cohort and comparison with ACTH-negative nonfunctioning pituitary adenomas.
    Ioachimescu AG; Eiland L; Chhabra VS; Mastrogianakis GM; Schniederjan MJ; Brat D; Pileggi AV; Oyesiku NM
    Neurosurgery; 2012 Aug; 71(2):296-303; discussion 304. PubMed ID: 22517250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delineating the Spectrum of Pituitary Adenoma Based on the WHO 2017 Classification.
    Paramita P; Shilpa R; Nandeesh BN; Yasha TC; Vani S
    Neurol India; 2024 Jan; 72(1):96-101. PubMed ID: 38443009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Implications of the New WHO Classification 2017 for Pituitary Tumors.
    Saeger W; Koch A
    Exp Clin Endocrinol Diabetes; 2021 Mar; 129(3):146-156. PubMed ID: 33690870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silent corticotroph pituitary adenomas: clinical characteristics, long-term outcomes, and management of disease recurrence.
    Strickland BA; Shahrestani S; Briggs RG; Jackanich A; Tavakol S; Hurth K; Shiroishi MS; Liu CJ; Carmichael JD; Weiss M; Zada G
    J Neurosurg; 2021 Dec; 135(6):1706-1713. PubMed ID: 33962375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No mutations in TPIT, a corticotroph-specific gene, in human tumoral pituitary ACTH-secreting cells.
    Bucciarelli LG; Pecori Giraldi F; Cavagnini F
    J Endocrinol Invest; 2005 Dec; 28(11):1015-8. PubMed ID: 16483181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and Pathological Aspects of Silent Pituitary Adenomas.
    Drummond J; Roncaroli F; Grossman AB; Korbonits M
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2473-2489. PubMed ID: 30020466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular, functional, and histopathological classification of the pituitary neuroendocrine neoplasms.
    Inomoto C; Tahara S; Oyama K; Kimura M; Matsuno A; Teramoto A; Osamura RY
    Brain Tumor Pathol; 2021 Jul; 38(3):183-188. PubMed ID: 34269950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.